Products
ocCure has two diagnostic tests in development.
The screening test will be used by women older than 40 years and women with family history for breast and ovarian cancer. The diagnostic test can detect ovarian cancer at an early stage, based on a simple blood sample, and enables an effective therapy of the disease.
The platinum response prediction test will be used by patients, who were diagnosed with ovarian cancer. For this patient population, the test predicts whether the tumor will respond to platinum-based chemotherapy or not.